HeartSciences Inc.
$2.05
▼
-2.95%
2026-04-21 07:21:01
heartsciences.com
NCM: HSCS
Explore HeartSciences Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$6.85 M
Current Price
$2.05
52W High / Low
$6.47 / $1.89
Stock P/E
—
Book Value
$0.83
Dividend Yield
—
ROCE
-1607.2%
ROE
-3.82%
Face Value
—
EPS
$-4.49
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
15
Beta
2.45
Debt / Equity
145.81
Current Ratio
1.19
Quick Ratio
0.41
Forward P/E
-0.74
Price / Sales
764.12
Enterprise Value
$7.1 M
EV / EBITDA
-0.91
EV / Revenue
818.46
Rating
None
Target Price
$10
EPS Forecast (FY)
—
Pros
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Inspira Technologies Oxy B.H.N. Ltd. | $0.59 | — | $21.71 M | — | -541.24% | -3.98% | $1.65 / $0.34 | $0.07 |
| 2. | ENvue Medical, Inc. | $1.51 | — | $5.59 M | — | -394.93% | -30.51% | $75.48 / $0.99 | $42 |
| 3. | enVVeno Medical Corporation | $12.08 | — | $7.92 M | — | -76.16% | -56.21% | $196.7 / $8.67 | $41.36 |
| 4. | Tivic Health Systems, Inc. | $1.13 | — | $3.25 M | — | -25.51% | -82.69% | $13.23 / $0.72 | $6.65 |
| 5. | WORK Medical Technology Group LTD | $1.2 | — | $1.6 M | — | -4.23% | -6.45% | $10,800 / $1.05 | $17.7 |
| 6. | Owlet, Inc. | $5.82 | — | $163.61 M | — | -19.96% | -8.02% | $16.94 / $3.08 | $0.71 |
| 7. | Pulsenmore Ltd. | $3.33 | — | $72.38 M | — | -33.09% | -17.62% | $1,468 / $1,000 | — |
Quarterly Results
Figures shown in M / B
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -1.93 M | -2.07 M | -1.87 M | -1.92 M | -2.37 M | — |
| Net Profit | -1.99 M | -2.35 M | -2.05 M | -2.09 M | -2.54 M | — |
| EPS in Rs | -0.62 | -0.74 | -0.65 | -0.66 | -0.8 | -2.27 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0.02 M | 0.01 M | 0.01 M |
| Operating Profit | -8.35 M | -6.31 M | -6.11 M | -4.71 M |
| Net Profit | -8.77 M | -6.61 M | -6.35 M | -4.83 M |
| EPS in Rs | -2.75 | -2.07 | -2 | -1.52 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 4.22 M | 9.5 M | 3.29 M | 2.09 M |
| Total Liabilities | 4.02 M | 2.19 M | 3.06 M | 8.15 M |
| Equity | 0.21 M | 7.32 M | 0.23 M | -6.06 M |
| Current Assets | 2.17 M | 7.35 M | 2.7 M | 1.93 M |
| Current Liabilities | 3.7 M | 1.75 M | 1.83 M | 3.47 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -7.41 M | -6.07 M | -5.77 M | -3.64 M |
| Investing CF | -0.03 M | -0.13 M | -0.02 M | -0 M |
| Financing CF | 2.73 M | 10.34 M | 6.53 M | 3.84 M |
| Free CF | -7.44 M | -6.2 M | -5.79 M | -3.65 M |
| Capex | -0.03 M | -0.13 M | -0.02 M | -0 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 261.17% | -64.17% | — | — |
| Earnings Growth % | -3.95% | -31.61% | — | — |
| Profit Margin % | -35511.87% | -123384.27% | -33592.57% | — |
| Operating Margin % | -33901.99% | -118698.33% | -32765.6% | — |
| Gross Margin % | 67.31% | 45.71% | 45.11% | — |
| EBITDA Margin % | -33096.75% | -116032.29% | -30822.2% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2024-05-17 | 1:0.01 |